Key facts
- It has raised $4.0M; the latest was Later Stage VC ($4.0M) in Oct 2025.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Mulin Butler Pharmaceutical
- ·The full record, as it builds
Funding rounds
No funding rounds for Mulin Butler Pharmaceutical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Mulin Butler Pharmaceutical
Operator of a digital pharmaceutical retail platform intended to enable compliant self-service access to medicines. The company offers unmanned smart medicine cabinets, integrated internet hospital connectivity, remote prescription review, and end-to-end traceability, enabling urban consumers and healthcare providers to access prescription and non-prescription medicines safely and compliantly.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2019
- Website
- mulin8000.com/
- Ownership
- Privately Held (backing)
Mulin Butler Pharmaceutical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Mulin Butler Pharmaceutical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Mulin Butler Pharmaceutical in its N-PORT filings yet. We sweep new filings monthly.